Aromatase inhibitors and enzyme stability

Endocrine-Related Cancer

Volumn 6, Issue 2, 1999, Pages 211-218

  Harada, N ^a   Honda, S I ^a   Hatano, O ^b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; AROMATASE INHIBITOR; ATAMESTANE; CYCLOHEXIMIDE; ESTROGEN; FADROZOLE; FOLLITROPIN; FORMESTANE; FORSKOLIN; GONADOTROPIN; MESSENGER RNA; PENTETRAZOLE; VOROZOLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHORIOCARCINOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME STABILITY; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTINEOPLASTIC AGENTS; AROMATASE; AROMATASE INHIBITORS; CHORIOCARCINOMA; CYCLOHEXIMIDE; ENZYME INHIBITORS; ENZYME STABILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; OVARY; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032973328     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0060211     Document Type: Article

References (33)

1. Abul-Hajj YJ, Iverson R & Kiang DT 1979 Aromatization of androgens by human breast cancer. Steroids 33 205-222.
2. Balthazart J, Foidart A & Harada N 1990 Immunocytochemical localization of aromatase in the brain. Brain Research 514 327-333.
3. Brodie AM 1994 Aromatase inhibitors in the treatment of breast cancer. Journal of Steroid Biochemistry and Molecular Biology 49 281-287.
4. Brodie AMH, Garrett W, Hendrickson JR, Tsai-Morris C-H, Marcotte CH & Robinson CH 1981a Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo. Steroids 38 693-702.
5. Brodie AMH, Hendrickson JR, Tsai-Morris CH, Garrett WM, Marcotte PA & Robinson CH 1981 b Inactivation of aromatase in vitro by 4-OHA and 4-acetoxyandrostenedione and sustained effects in vivo. Steroids 38 693-702.
6. Bulun SE, Price TM, Aitken J, Mahendroo MS & Simpson ER 1993 A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. Journal of Clinical Endocrinology and Metabolism 77 1622-1628.
7. Esteban JM, Warsi Z, Haniu M, Hall P, Shively JE & Chen S 1992 Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation. American Journal of Pathology 140 337-343.
8. Foidart A, Harada N & Balthazart J 1994 Effects of steroidal and non steroidal aromatase inhibitors on sexual behavior and aromatase-immunoreactive cells and fibers in the quail brain. Brain Research 657 105-123.
9. Harada N 1988 Novel properties of human placental aromatase as cytochrome P-450; purification and characterization of a unique form of aromatase. Journal of Biochemistry 103 106-113.
10. Harada N & Omura T 1980 Participation of cytochrome P-450 in the reduction of nitro compounds by rat liver microsomes. Journal of Biochemistry 87 1539-1554.
11. Harada N & Yamada K 1992 Ontogeny of aromatase messenger ribonucleic acid in mouse brain: fluorometrical quantitation by polymerase chain reaction. Endocrinology 131 2306-2312.
12. Harada N, Utsumi T & Takagi Y 1995 Molecular and epidemiological analyses of abnormal expression of aromatase in breast cancer. Pharmacogenetics 5 59-64.
13. Hatano O, Takayama K, Imai T, Waterman MR, Takakusu A, Omura T & Morohashi K 1994 Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development 120 2787-2797.
14. Henderson D, Norbisrath G & Kerb U 1986 1-Methyl-1,4-androstadiene-3,17-dione (SH 489): characterization of an irreversible inhibitor of estrogen biosynthesis. Journal of Steroid Biochemistry and Molecular Biology 24 303-306.
15. Jakab RL, Horvath TL, Leranth C, Harada N & Naftolin F 1993. Aromatase immunoreactivity in the rat brain: gonadectomy-sensitive hypothalamic neurons and an unresponsive 'limbic ring' of the lateral septum-bed nucleus-amygdala complex. Journal of Steroid Biochemistry and Molecular 44 481-498.
16. Kitawaki J, Yoshida N & Osawa Y 1989 An enzyme-linked immunosorbent assay for quantitation of aromatase cytochrome P-450. Endocrinology 124 1417-1423.
17. Lu Q, Nakmura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G & Brodie A 1996 Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 137 3061-3068.
18. Marsh DA, Brodie HJ, Garrett WM, Tsai-Morris CH & Brodie AMH 1985 Aromatase inhibitors - synthesis and biological activity of androstenedione derivatives. Journal of Medicinal Chemistry 28 788-795.
19. Miller WR & Mullen P 1993 Factors influencing aromatase activity in the breast. Journal of Steroid Biochemistry and Molecular Biology 44 597-604.
20. Miller WR & O'Neill J 1987 The importance of local synthesis of estrogen within the breast. Steroids 50 537-548.
21. Noble LS, Simpson ER, Johns A & Bulun SE 1996 Aromatase expression in endometriosis. Journal of Clinical Endocrinology and Metabolism 81 174-179.
22. Omura T & Sato R 1964 The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry 239 2379-2385.
23. Santen RJ & Misbin RI 1981 Aminoglutethimide: review of pharmacology and clinical uses. Pharmacotherapy 1 95-120.
24. Santen RJ, Martel J, Hoagland M, Naftolin F, Roa L, Harada N, Hafer L, Zaino R & Santner SJ 1994 Stromal spindle cells contain aromatase in human breast tumors. Journal of Clinical Endocrinology and Metabolism 79 627-632.
25. Santner SJ, Feil PD & Santen RJ 1984 In situ estrogen production via the estrogen sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. Journal of Clinical Endocrinology and Metabolism 59 29-33.
26. Sasano H, Nagura H, Harada N, Goukon Y & Kimura M 1994 Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Human Pathology 25 530-535.
27. Schimke RT 1964 The importance of both synthesis and degradation in the control of arginase levels in rat liver. Journal of Biological Chemistry 239 3808-3817.
28. Schimke RT, Sweeney EW & Berlin CM 1965 The roles of synthesis and degradation in the control of rat liver tryptophan pyrrolase. Journal of Biological Chemistry 240 322-331.
29. Steele RE, Mellor LB, Sawyer WK, Wasvary JM & Brown RE 1987 In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS16949A. Steroids 50 147-161.
30. Takemori S, Sato H, Gomi T, Suhara K & Katagiri M 1975 Purification and properties of cytochrome P-450 11β from adrenocortical mitochondria. Biochemical and Biophysical Research Communications 67 1151-1157.
31. Tan J & Muto N 1986 Purification and reconstitution properties of human placental aromatase; a cytochrome P-450-type monooxygenase. European Journal of Biochemistry 156 243-250.
32. Utsumi T, Harada N, Maruta M & Takagi Y 1996 Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. Journal of Clinical Endocrinology and Metabolism 81 2344-2349.
33. Vanden Bossche H, Willemsens G, Roels I, Bellens D, Moereels H, Coene MC, LeJeune L, Lauwers W & Janssen PAJ 1990 R76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent estrogen synthesis. Biochemical Pharmacology 40 1707-1718.